ReDO_DB: the repurposing drugs in oncology database.
Ecancermedicalscience
; 12: 886, 2018.
Article
en En
| MEDLINE
| ID: mdl-30679953
Repurposing is a drug development strategy that seeks to use existing medications for new indications. In oncology, there is an increased level of activity looking at the use of non-cancer drugs as possible cancer treatments. The Repurposing Drugs in Oncology (ReDO) project has used a literature-based approach to identify licensed non-cancer drugs with published evidence of anticancer activity. Data from 268 drugs have been included in a database (ReDO_DB) developed by the ReDO project. Summary results are outlined and an assessment of clinical trial activity also described. The database has been made available as an online open-access resource (http://www.redo-project.org/db/).
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Ecancermedicalscience
Año:
2018
Tipo del documento:
Article
País de afiliación:
Bélgica
Pais de publicación:
Reino Unido